BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16483388)

  • 21. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life.
    Giglio V
    Am J Cardiol; 2007 Jan; 99(1):147-8. PubMed ID: 17196482
    [No Abstract]   [Full Text] [Related]  

  • 22. Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy.
    Sumanaru D; Josseran L; Essid A; Mbieleu B; Haegy I; Bergounioux J
    Pediatr Cardiol; 2019 Mar; 40(3):668-670. PubMed ID: 30796500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and therapeutic challenges.
    Ober MD; Del Priore LV; Tsai J; Lopez R; Lobes LA; Puklin JE; Young T
    Retina; 2006 Apr; 26(4):462-7. PubMed ID: 16603967
    [No Abstract]   [Full Text] [Related]  

  • 24. X marks the spot: Duchenne's cardiomyopathy.
    Lee JJ; Patel SM; Saba SF
    Am J Med; 2014 Jul; 127(7):e13-4. PubMed ID: 24726503
    [No Abstract]   [Full Text] [Related]  

  • 25. Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular Dystrophy.
    Stalens C; Motté L; Béhin A; Ben Yaou R; Leturcq F; Bassez G; Laforêt P; Fontaine B; Ederhy S; Masingue M; Saadi M; Louis SL; Berber N; Stojkovic T; Duboc D; Wahbi K
    J Neuromuscul Dis; 2021; 8(4):495-502. PubMed ID: 33814458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscular Dystrophy Campaign Funded Workshop on Management of Scoliosis in Duchenne Muscular Dystrophy 24 January 2005, London, UK.
    Muntoni F; Bushby K; Manzur AY
    Neuromuscul Disord; 2006 Mar; 16(3):210-9. PubMed ID: 16497502
    [No Abstract]   [Full Text] [Related]  

  • 27. Early detection of cardiomyopathy in Duchenne muscular dystrophy, is there a role for MRI?
    Baur LH
    Int J Cardiovasc Imaging; 2009 Jan; 25(1):69-70. PubMed ID: 18855120
    [No Abstract]   [Full Text] [Related]  

  • 28. ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies.
    Russo V; Papa AA; Williams EA; Rago A; Palladino A; Politano L; Nigro G
    Trends Cardiovasc Med; 2018 Jul; 28(5):330-337. PubMed ID: 29292032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiac problems in patients with progressive muscular dystrophy].
    Danzig V; Fiksa J; Hani AB; Havlová M; Sonka K
    Sb Lek; 2003; 104(3):273-8. PubMed ID: 15224533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs.
    Colan SD
    Circulation; 2005 Nov; 112(18):2756-8. PubMed ID: 16267247
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
    El-Aloul B; Altamirano-Diaz L; Zapata-Aldana E; Rodrigues R; Malvankar-Mehta MS; Nguyen CT; Campbell C
    Neuromuscul Disord; 2017 Jan; 27(1):4-14. PubMed ID: 27815032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 2009 perspective on the 2004 American Thoracic Society statement, "respiratory care of the patient with Duchenne muscular dystrophy".
    Finder JD
    Pediatrics; 2009 May; 123 Suppl 4():S239-41. PubMed ID: 19420152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy.
    Hor KN; Mah ML; Johnston P; Cripe TP; Cripe LH
    Neuromuscul Disord; 2018 Sep; 28(9):711-716. PubMed ID: 30064893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.
    Townsend D; Yasuda S; Metzger J
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):99-109. PubMed ID: 17187461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaesthesia for non-cardiac surgery in patient with Becker's muscular dystrophy supported with a left ventricular assist device.
    Webb ST; Patil V; Vuylsteke A
    Eur J Anaesthesiol; 2007 Jul; 24(7):640-2. PubMed ID: 17632873
    [No Abstract]   [Full Text] [Related]  

  • 36. Myocardial cell damage in Duchenne muscular dystrophy.
    Ramaciotti C; Iannaccone ST; Scott WA
    Pediatr Cardiol; 2003; 24(5):503-6. PubMed ID: 14627325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac involvement determines the prognosis of Duchenne muscular dystrophy.
    Finsterer J; Stollberger C
    Indian J Pediatr; 2007 Feb; 74(2):209; author reply 210-2. PubMed ID: 17337840
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne's muscular dystrophy: relationship to clinical outcome.
    Giatrakos N; Kinali M; Stephens D; Dawson D; Muntoni F; Nihoyannopoulos P
    Heart; 2006 Jun; 92(6):840-2. PubMed ID: 16387815
    [No Abstract]   [Full Text] [Related]  

  • 39. A noninvasive means of detecting preclinical cardiomyopathy in Duchenne muscular dystrophy?
    Towbin JA
    J Am Coll Cardiol; 2003 Jul; 42(2):317-8. PubMed ID: 12875770
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac treatment in neuro-muscular diseases.
    Nigro G; Politano L; Passamano L; Palladino A; De Luca F; Nigro G; Comi LI
    Acta Myol; 2006 Dec; 25(3):119-23. PubMed ID: 17626520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.